CliffBio
small molecule

MORPHINE SULFATE

MORPHINE SULFATE

Loss of exclusivity—loss of exclusivity
CompanyTris. →See this company's full patent-cliff portfolio

Drug detail

Brand nameMORPHINE SULFATE
Active ingredientMORPHINE SULFATE
Strength20MG/5ML
Dosage formSOLUTION
RouteORAL
ModalitySmall molecule
FDA approvalMay 2016
Marketing statusDISCN

More from Tris.

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.

MORPHINE SULFATE patent cliff — loss of exclusivity — | CliffBio